These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 3300961

  • 1. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
    Ocadiz R, Sauceda R, Cruz M, Graef AM, Gariglio P.
    Cancer Res; 1987 Aug 01; 47(15):4173-7. PubMed ID: 3300961
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of human papillomavirus type 16 DNA sequences and c-myc oncogene alterations in uterine-cervix carcinoma.
    Ocádiz R, Sauceda R, Salcedo M, Ortega V, Rodríguez H, Gordillo C, Chávez P, Gariglio P.
    Arch Invest Med (Mex); 1989 Aug 01; 20(4):355-62. PubMed ID: 2562235
    [Abstract] [Full Text] [Related]

  • 3. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP, Castillo SG, Nguyen CV, Hickey RC, Samaan NA.
    Anticancer Res; 1990 Aug 01; 10(1):189-92. PubMed ID: 2185686
    [Abstract] [Full Text] [Related]

  • 4. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
    Mitra AB, Murty VV, Pratap M, Sodhani P, Chaganti RS.
    Cancer Res; 1994 Feb 01; 54(3):637-9. PubMed ID: 7905784
    [Abstract] [Full Text] [Related]

  • 5. [Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix].
    Riou G, Barrois M, Tordjman I, Dutronquay V, Orth G.
    C R Acad Sci III; 1984 Feb 01; 299(14):575-80. PubMed ID: 6097348
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G.
    Oncogene Res; 1988 Feb 01; 3(1):21-31. PubMed ID: 2905033
    [Abstract] [Full Text] [Related]

  • 7. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
    Riou G, Barrois M, Sheng ZM, Duvillard P, Lhomme C.
    Oncogene; 1988 Sep 01; 3(3):329-33. PubMed ID: 3060795
    [Abstract] [Full Text] [Related]

  • 8. The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer.
    Riou GF, Bourhis J, Le MG.
    Anticancer Res; 1990 Sep 01; 10(5A):1225-31. PubMed ID: 2173473
    [Abstract] [Full Text] [Related]

  • 9. Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors.
    Garte SJ, Burns FJ, Ashkenazi-Kimmel T, Felber M, Sawey MJ.
    Cancer Res; 1990 May 15; 50(10):3073-7. PubMed ID: 2185880
    [Abstract] [Full Text] [Related]

  • 10. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM, Swallow JE, Brammar WJ, Whittaker JL, Walker RA.
    Oncogene; 1987 May 15; 1(4):423-30. PubMed ID: 3330785
    [Abstract] [Full Text] [Related]

  • 11. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
    Ngan HY, Cheung AN, Liu SS, Cheng DK, Ng TY, Wong LC.
    Oncol Rep; 2001 May 15; 8(3):557-61. PubMed ID: 11295080
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kokawa K, Shikone T, Otani T, Nakano R.
    Cancer; 1999 Apr 15; 85(8):1799-809. PubMed ID: 10223575
    [Abstract] [Full Text] [Related]

  • 13. [Amplification of the expression of the c-myc oncogene in bronchial epidermoid carcinoma in man].
    Douc-Rasy S, Terrier P, Kemeny JL, Amouroux J, Riou G.
    C R Acad Sci III; 1985 Apr 15; 301(13):621-6. PubMed ID: 3937573
    [Abstract] [Full Text] [Related]

  • 14. [Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas].
    Tanimoto H, Nagai N, Fujimoto H, Ohta S, Ohama K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 May 15; 44(5):566-70. PubMed ID: 1619315
    [Abstract] [Full Text] [Related]

  • 15. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
    Petrov SV, Mazurenko NN, Sukhova NM, Moroz IP, Katsenel'son VM, Raĭkhlin NT, Kiselev FL.
    Arkh Patol; 1994 May 15; 56(4):22-31. PubMed ID: 7848100
    [Abstract] [Full Text] [Related]

  • 16. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
    Jungehülsing M, Volling P.
    HNO; 1994 May 15; 42(5):280-7. PubMed ID: 8050916
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.
    Yokota J, Wada M, Yoshida T, Noguchi M, Terasaki T, Shimosato Y, Sugimura T, Terada M.
    Oncogene; 1988 Jun 15; 2(6):607-11. PubMed ID: 2838790
    [Abstract] [Full Text] [Related]

  • 18. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M, Noguchi M, Shimosato Y, Sekiya T.
    Cancer Res; 1989 Dec 01; 49(23):6474-9. PubMed ID: 2573414
    [Abstract] [Full Text] [Related]

  • 19. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
    Riou G, Sheng ZM, Zhou D, Lusinchi A, Le Doussal V, Barrois M.
    Bull Cancer; 1990 Dec 01; 77(4):341-7. PubMed ID: 2191730
    [Abstract] [Full Text] [Related]

  • 20. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ, Frierson HF, Williams ME.
    Mod Pathol; 1993 Nov 01; 6(6):654-9. PubMed ID: 7905628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.